Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors

NCT02150408 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Gastro-Entero-Pancreatic Tumors (GEPs)

Interventions

OTHER: PET-CT

Sponsor

Assistance Publique Hopitaux De Marseille